ISSN: 2960-1959
Publisher
Original Articles

Cancer Publications in One Year (2022): A Cross-Sectional Study

Fenk Mariwan Mohemed
College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq
Binaiy Nasih Fatih
College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq
Abdullah Abdulrahman Qadir
College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq
Shalaw H. Abdalla
Hiwa Cancer Hospital, Sulaimani Directorate of Health, Sulaimani, Kurdistan, Iraq.
Zana H. Mahmood
Smart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq
Abstract
1043
Downloads
439
Published: May 10, 2023
PDF
PDF

Abstract

Introduction

Cancer is the uncontrollable and abnormal division of cells in a specific part of the body, which can spread to adjacent areas. The number of scientific publications on cancer has increased significantly over the past few decades. The objective of the current study is to evaluate scientific publications on cancer in 2022.

Methods

A cross-sectional study was conducted on published papers on cancer in 2022. The data were collected online from the Google Scholar search engine and recorded in Microsoft Excel 2010. The extracted data were calculated and thoroughly re-evaluated, and they were presented as frequencies and percentages.

Results

A total of 167,129 medical studies on cancer in various body organs were collected for the study, with 37,500 studies specifically focused on breast cancer. This represented the highest number of studies in 2022, while only 4 articles were specific to glottis cancer, marking the lowest number in that year.

Conclusion

The existence of a gap between the incidence rate of each cancer type and scientific literature may lead to a defect in our understanding of the nature of the diseases.

References

  1. Panther EJNational Cancer Institute. What Is Cancer?. National Cancer Institute. Cancer.gov; 2021. https://www.cancer.gov/about-cancer/understanding/what-is-cancer
  2. Hejmadi M. Introduction to Cancer Biology. Bookboon; 2010. https://bookboon.com/en/introduction-to-cancer-biology-ebook?mediaType=ebook
  3. Chandraprasad MS, Dey A, Swamy MK. Introduction to cancer and treatment approaches. Paclitaxel. 2022:(pp. 1-27). Academic Press. doi:10.1016/B978-0-323-90951-8.00010-2
  4. Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, et al. The multitude and diversity of environmental carcinogens. Environmental Research. 2007;105(3):414–29. doi:10.1016/j.envres.2007.07.002
  5. Meza-Junco J, Montao-Loza A, Aguayo-Gonzalez A. Molecular basis of cancer. Revista de Investigacin Clnica. 2006;58(1):56–70. https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDREVISTA=77&IDARTICULO=18978&IDPUBLICACION=1941
  6. Alvarez EM, Force LM, Xu R, Compton K, Lu D, Henrikson HJ, et al. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Oncology. 2022;23(1):27–52. doi:10.1016/S1470-2045(21)00581-7
  7. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. doi:10.3322/caac.21660
  8. Cancer Research UK. Cancer Statistics for the UK. Cancer Research UK. CRUK; 2018. https://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk
  9. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. The Lancet Gastroenterology & Hepatology. 2019;4(7):511–8. doi:10.1016/S2468-1253(19)30147-5
  10. Muhialdeen AS, Ahmed JO, Baba HO, Abdullah IY, Hassan HA, Najar KA, et al. Kscien’s List; A New Strategy to Discourage Predatory Journals and Publishers (Second Version). Barw Medical Journal. 2023; 1(1):30-32. doi:10.58742/bmj.v1i1.17
  11. Cancer Biology. NIH Intramural Research Program. 2012. https://irp.nih.gov/our-research/scientific-focus-areas/cancer-biology
  12. Cancer Research UK. Types of cancer. Cancer Research UK. 2014. https://www.cancerresearchuk.org/what-is-cancer/how-cancer-starts/types-of-cancer#:~:text=There%20are%20more%20than%20200
  13. Abdullah AM, Qaradakhy AJ, Ahmed MM, Salih AM, Omar SS, Kakamad FH, et al. Thyroid collision tumors; A case series with literature review. Annals of Medicine and Surgery. 2022; 76:103444. doi:10.1016/j.amsu.2022.103444
  14. Brown ML, Goldie SJ, Draisma G, Harford J, Lipscomb J. Health Service Interventions for Cancer Control in Developing Countries. 2nd ed. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. PubMed. Washington (DC): World Bank; 2006. https://www.ncbi.nlm.nih.gov/books/NBK11756/
  15. Salh AM, Abdullah AM, Kakamad FH, Hammood ZD, Mikael TM, Hassan SH. Synchronous occurrence of breast fibroadenoma with osseous metaplasia and invasive lobular carcinoma; a case report with literature review. International Journal of Surgery Open. 2022; 38:100434. doi:10.1016/j.ijso.2021.100434
  16. Patel AP, Fisher JL, Nichols E, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(4):376-93. doi:10.1016/S1474-4422(18)30468-X
  17. American Association of Neurological Surgeons. Glioblastoma Multiforme – Symptoms, Diagnosis and Treatment Options. Aans.org. 2019. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Glioblastoma-Multiforme
  18. Inamura K. Lung cancer: understanding its molecular pathology and the 2015 WHO classification. Frontiers in oncology. 2017; 7:193-99. doi:10.3389/fonc.2017.00193
  19. Key Statistics for Thyroid Cancer. American Cancer Society; 2019. https://www.cancer.org/cancer/thyroid-cancer/about/key-statistics.html
  20. Salh AM, Ahmed SF, Omar SS, Hassan SH, Mohammed SH, Kakamad FH. Medullary thyroid carcinoma with normal serum calcitonin and carcinoembryonic levels; a case with review of literature. International Journal of Surgery Open. 2022; 39:100443. doi:10.1016/j.ijso.2022.100443
  21. International Agency for cancer research. World Health Organization;2022. https://www.iarc.who.int/wp-content/uploads/2022/10/pr320_E.pdf
  22. Ullah A, Khan J, Waheed A, Sharma N, Pryor E, Stumpe T, et al. Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives. Cancer. 2022;14(6):1426. doi:10.3390%2Fcancers14061426
  23. Parathyroid Cancer - Statistics. Cancer.net. 2012. https://www.cancer.net/cancer-types/parathyroid-cancer/statistics
  24. Esophageal Cancer - National Cancer Institute. www.cancer.gov. 2021. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/esophageal
  25. Epidemiology of Bone Cancer: An Overview | American Academy of Neurological and Orthopaedic Surgeons. 2014. https://aanos.org/epidemiology-of-bone-cancer-an-overview/
  26. Harnisch-Weidauer L. Cancer Rates by Country [Updated 2022]. Dana-Farber Cancer Institute. 2022. https://blog.dana-farber.org/insight/2022/01/which-countries-have-the-highest-and-lowest-cancer-rates/
  27. Watkins EJ. Overview of breast cancer. Journal of the American Academy of PAs. 2019 32(10):13-7. doi:10.1097/01.jaa.0000580524.95733.3d
  28. Hammood ZD, Mohammed SH, Abdulla BA, Omar SS, Naqar S, Salih AM, et al. Ductal carcinoma in situ arising from fibroadenoma; a rare case with review of literature. Annals of Medicine and Surgery. 2022; 75:103449. doi:10.1016/j.amsu.2022.103449
  29. Hammood ZD, Salih AM, Latif S, Abdullah HO, Ali RK, Kakamad FH. Primary diffuse B-cell non-Hodgkin's breast lymphoma; A case report with a brief literature review. Annals of Medicine and Surgery. 2022; 75:103310. doi:10.1016/j.amsu.2022.103310
  30. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA: A Cancer Journal for Clinicians. 2022;72(1):7–33. doi:10.3322/caac.21708
  31. Polyak K. Breast cancer: origins and evolution. Journal of Clinical Investigation. 2007; 117(11):3155–63. doi:10.1172/JCI33295
  32. Van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. British Journal of Cancer. 2019;121(4):285–92. doi:10.1038/s41416-019-0478-6
  33. Kerlikowske K. Epidemiology of Ductal Carcinoma In Situ. Journal of the National Cancer Institute Monographs. 2010;2010(41):139–41. doi:10.1093%2Fjncimonographs%2Flgq027
  34. Aguiar PN, Barreto CMN, Forones NM, Tadokoro H, De Mello RA. Small Intestine Cancer. International Manual of Oncology Practice. 2019;391–404. doi:10.1007/978-3-030-16245-0_19
  35. Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. International Journal of Epidemiology. 1996;25(4):722–8. doi:10.1093/ije/25.4.722
  36. Ernst J. Kuipers, William M. Grady, David Lieberman, Thomas Seufferlein, Joseph J. Sung, Petra G. Boelens et al. Colorectal cancer. Nature Reviews Disease Primers.2015. doi:10.1038/nrdp.2015.65.
  37. Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi REM, Corcione F. Worldwide burden of colorectal cancer: a review. Updates in Surgery. 2016;68(1):7–11. doi:10.1007/s13304-016-0359y
  38. Patel AR, Klein EA. Risk factors for prostate cancer. Nature Clinical Practice Urology. 2009;6(2):87–95. doi:10.1038/ncpuro1290.
  39. Chobanian N, Dietrich III CS. Ovarian cancer. Surgical Clinics of North America. 2008;88(2):285-99. doi:10.1016/j.suc.2007.12.002.
  40. Malvezzi M, Carioli G, Rodriguez T, Negri E, La Vecchia C. Global trends and predictions in ovarian cancer mortality. Annals of Oncology. 2016;27(11):2017-25. doi:10.1093/annonc/mdw306.

Similar Articles

You may also start an advanced similarity search for this article.

Keywords
Copyright (c) 2023 Barw Medical Journal Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Send mail to Author

Send Cancel
Copyright© Barw Publications 2023. All rights reserved
Themes by Openjournaltheme.com